PATENT CLAIM ANALYSIS

Application Number: 16139461
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "04400A"]

Abstract:
Provided is siRNA effective for the treatment of fibrosis and a pharmaceutical containing the siRNA.

Claim (Index 2):
An siRNA having a full length of 30 or fewer nucleotides and targeting a sequence comprising 25 or less consecutive bases selected from the group consisting of bases at positions 1285 to 1305, bases at positions 1548 to 1579, and bases at positions 1700 to 1726 of SEQ ID NO: 1.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.14286
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15465961', '15000204', '13824080', '14272898', '15536006']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7342347613693608
- 35 USC 102 Novelty (BERT): 0.5110753805137991
- Combined Prediction Score: 0.7119188232838046
- Mean Citation Score: 263.020996
- Max Citation Score: 288.88098
- Similarity Product: 238.2869955416429

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test